Login / Signup

Denosumab and Risk of Community-acquired Pneumonia: A Population-based Cohort Study.

Houchen LyuSizheng ZhaoJiatian LiXiaoxiao LiYilun WangDongxing XieChao ZengGuang-Hua LeiYuqing ZhangHui Li
Published in: The Journal of clinical endocrinology and metabolism (2022)
Denosumab does not significantly increase the susceptibility of community-acquired pneumonia and could possibly be safely used for the management of osteoporosis.
Keyphrases
  • community acquired pneumonia
  • bone mineral density
  • postmenopausal women
  • giant cell
  • body composition